BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29561922)

  • 1. The presence of Interleukin-13 in nasal lavage may be a predictor of nasal polyposis in pediatric patients with cystic fibrosis.
    Manji J; Thamboo A; Tacey M; Garnis C; Chadha NK
    Rhinology; 2018 Sep; 56(3):261-267. PubMed ID: 29561922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the SNOT-22 and UPSIT to appropriately select pediatric patients with cystic fibrosis who should be referred to an otolaryngologist: cross-sectional study.
    Thamboo A; Santos RC; Naidoo L; Rahmanian R; Chilvers MA; Chadha NK
    JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):934-9. PubMed ID: 25144751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D₃ deficiency and its association with nasal polyposis in patients with cystic fibrosis and patients with chronic rhinosinusitis.
    Konstantinidis I; Fotoulaki M; Iakovou I; Chatziavramidis A; Mpalaris V; Shobat K; Markou K
    Am J Rhinol Allergy; 2017 Nov; 31(6):395-400. PubMed ID: 29122084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and management of nasal polyposis in cystic fibrosis.
    Mainz JG; Koitschev A
    Curr Allergy Asthma Rep; 2012 Apr; 12(2):163-74. PubMed ID: 23520643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines profile in cystic fibrosis patients with nasal polyps.
    Nunes FB; Becker CG; Becker HM; Araujo RN; Guimarães RE
    Rev Laryngol Otol Rhinol (Bord); 2009; 130(3):163-7. PubMed ID: 20345072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators.
    Claeys S; Van Hoecke H; Holtappels G; Gevaert P; De Belder T; Verhasselt B; Van Cauwenberge P; Bachert C
    Clin Exp Allergy; 2005 Apr; 35(4):467-72. PubMed ID: 15836755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell and cytokine profile in nasal secretions in cystic fibrosis.
    Bergoin C; Gosset P; Lamblin C; Bolard F; Turck D; Tonnel AB; Wallaert B
    J Cyst Fibros; 2002 Sep; 1(3):110-5. PubMed ID: 15463816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of sinonasal disease onset, progression, and severity in pediatric cystic fibrosis patients.
    Weinstock MS; Shaffer AD; Stapleton AL
    Am J Otolaryngol; 2021; 42(5):103016. PubMed ID: 33836483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal lavage microbiome, but not nasal swab microbiome, correlates with sinonasal inflammation in children with cystic fibrosis.
    Chung J; Boutin S; Frey DL; Joachim C; Mall MA; Sommerburg O
    J Cyst Fibros; 2024 Mar; 23(2):226-233. PubMed ID: 38199892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal lavage levels of granulocyte-macrophage colony-stimulating factor and chronic nasal hypereosinophilia.
    De Corso E; Baroni S; Lucidi D; Battista M; Romanello M; Autilio C; Morelli R; Di Nardo W; Passali GC; Sergi B; Bussu F; Fetoni AR; Zuppi C; Paludetti G
    Int Forum Allergy Rhinol; 2015 Jun; 5(6):557-62. PubMed ID: 25821067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and management of nasal polyposis in cystic fibrosis.
    Mainz JG; Koitschev A
    Curr Allergy Asthma Rep; 2012 Apr; 12(2):163-74. PubMed ID: 22350539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profile in subjects with Cystic Fibrosis and nasal polyposis compared to patients with no nasal disorders.
    Nunes FB; Castro MC; Silva TM; Araújo RN; Becker HM; Crosara PF; Guimarães RE
    Braz J Otorhinolaryngol; 2010; 76(1):25-8. PubMed ID: 20339685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive nasal polyposis in a patient with newly diagnosed cystic fibrosis.
    Olszowiec-Chlebna M; Trzciński K; Stelmach I
    Adv Respir Med; 2017; 85(2):121-123. PubMed ID: 28440538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen therapy and nasal polyposis in cystic fibrosis patients.
    Lindstrom DR; Conley SF; Splaingard ML; Gershan WM
    J Otolaryngol; 2007 Oct; 36(5):309-14. PubMed ID: 17963671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assays.
    Fuchs T; Zlamy M; Zöggeler T; Appelt D; Niedermayr K; Siedl A; Gasser V; Eder J; Ellemunter H
    BMC Pulm Med; 2024 Jun; 24(1):286. PubMed ID: 38890643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of immunoglobulin E, interleukin-5 and granulocyte-macrophage colony-stimulation factor in nasal polyps tissue].
    Cao Z; Lü H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 May; 18(5):276-8. PubMed ID: 15311508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection?
    De Gaudemar I; Contencin P; Van den Abbeele T; Munck A; Navarro J; Narcy P
    Rhinology; 1996 Dec; 34(4):194-7. PubMed ID: 9050094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic infection with Pseudomonas aeruginosa in cystic fibrosis: a risk factor for nasal polyposis after lung transplantation.
    Vital D; Holzmann D; Boehler A; Hofer M
    Transplantation; 2013 Jun; 95(12):1548-53. PubMed ID: 23624545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.
    Janhsen WK; Arnold C; Hentschel J; Lehmann T; Pfister W; Baier M; Böer K; Hünniger K; Kurzai O; Hipler UC; Mainz JG
    Med Microbiol Immunol; 2016 Oct; 205(5):485-500. PubMed ID: 27377929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.
    Rozsasi A; Heinemann A; Keck T
    Am J Rhinol Allergy; 2011; 25(6):e251-4. PubMed ID: 22185734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.